rawfin.tv
FocalTherics Affirms 2026 HIFU Revenue Outlook, Completes $40M Equity Offering
EarningsstocksAI Generated

FocalTherics Affirms 2026 HIFU Revenue Outlook, Completes $40M Equity Offering

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

FocalTherics reiterated its 2026 revenue guidance for HIFU products, projecting $50 million to $54 million. The medical device company also announced the successful closure of a $40 million equity offering.

FocalThericsHealthcareEquity OfferingRevenue GuidanceMedical Devices

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks